Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma
Metabolic reprogramming is a hallmark of clear cell renal cell carcinoma (ccRCC) progression. Here, we used genome-scale metabolic modeling to elucidate metabolic reprogramming in 481 ccRCC samples and discovered strongly coordinated regulation of glycosaminoglycan (GAG) biosynthesis at the transcri...
Main Authors: | Francesco Gatto, Nicola Volpi, Helén Nilsson, Intawat Nookaew, Marco Maruzzo, Anna Roma, Martin E. Johansson, Ulrika Stierner, Sven Lundstam, Umberto Basso, Jens Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716305009 |
Similar Items
-
Prognostic value of plasma and urine glycosaminoglycan scores in clear cell renal cell carcinoma
by: Francesco Gatto, et al.
Published: (2016-11-01) -
Glycosaminoglycan (GAG) scores for surveillance of recurrence in Leibovich Points ≥5 non-metastatic clear cell renal cell carcinoma: AURORAX-0087A trial in progress report
by: S. Dabestani, et al.
Published: (2020-11-01) -
Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC
by: Sai Krishnaraya Doppalapudi, et al.
Published: (2021-08-01) -
Solitary metastatic clear cell carcinoma to the spleen
by: Mohamed A. Zayed, et al.
Published: (2011-10-01) -
Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma
by: Sharon Del Vecchio, et al.
Published: (2018-10-01)